Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia.
Cerny-Reiterer S, Rabenhorst A, Stefanzl G, Herndlhofer S, Hoermann G, Müllauer L, Baumgartner S, Beham-Schmid C, Sperr WR, Mannhalter C, Sill H, Linkesch W, Arock M, Hartmann K, Valent P.
Cerny-Reiterer S, et al. Among authors: linkesch w.
Oncotarget. 2015 Feb 20;6(5):3071-84. doi: 10.18632/oncotarget.3074.
Oncotarget. 2015.
PMID: 25605011
Free PMC article.